Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27838 | 17297427 | Ann Hepatol | Fatty liver: experience from western India. | 2007 | Details |
| A27840 | 17295757 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. | 2007 | Details |
| A27846 | 17273155 | J Hum Hypertens | Hypertension and fatty liver: guilty by association? | 2007 | Details |
| A27855 | 17242448 | Nutr Clin Pract | Nonalcoholic Fatty liver disease and obesity. | 2007 | Details |
| A27863 | 17220609 | Intern Med | 1. Fatty liver and non-alcoholic steatohepatitis. | 2007 | Details |
| A27883 | 17142131 | Metabolism | The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. | 2006 | Details |
| A27897 | 17063117 | J Clin Gastroenterol | Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. | 2007 | Details |
| A27920 | 17013519 | Acta Cir Bras | Nonalcoholic fatty liver disease and obesity. | 2006 | Details |
| A27948 | 16925194 | Surg Obes Relat Dis | Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. | 2006 | Details |
| A27958 | 16899321 | J Hepatol | Hepatic histology in obese patients undergoing bariatric surgery. | 2006 | Details |
| A27959 | 16898568 | Curr Diab Rep | Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. | 2006 | Details |
| A27988 | 16787375 | Mini Rev Med Chem | Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease. | 2006 | Details |
| A27993 | 16768124 | Nihon Rinsho | [Clinical utility of angiotensin II receptor antagonist]. | 2006 | Details |
| A28008 | 16751709 | J Endocrinol Invest | Endocannabinoids as novel mediators of liver diseases. | 2006 | Details |
| A28016 | 16709309 | Curr Med Res Opin | Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. | 2006 | Details |
| A28019 | 16706822 | J Gastroenterol Hepatol | Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. | 2006 | Details |
| A28035 | 16637558 | Pediatr Ann | Nonalcoholic fatty liver disease. | 2006 | Details |
| A28051 | 28286458 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. | 2006 | Details |
| A28056 | 16553034 | J Endocrinol Invest | Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. | 2006 | Details |
| A28057 | 16545157 | Obes Surg | Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. | 2006 | Details |
| A28061 | 16540768 | J Clin Gastroenterol | The epidemiology of nonalcoholic fatty liver disease in adults. | 2006 | Details |
| A28063 | 16540765 | J Clin Gastroenterol | Diagnostic evaluation of nonalcoholic fatty liver disease. | 2006 | Details |
| A28074 | 16506276 | Diabetes Metab Res Rev | Diabetes in chronic liver disease: from old concepts to new evidence. | 2006 | Details |
| A28108 | 16398679 | Pathol Int | Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder. | 2006 | Details |
| A28140 | 16275057 | Hepatol Res | Clinical and pathological features of non-alcoholic steatohepatitis. | 2005 | Details |
| A28151 | 16255293 | Rev Prat | [Epidemiology and natural history of cirrhosis]. | 2005 | Details |
| A28167 | 16231591 | Eur Rev Med Pharmacol Sci | Steatosis and portal hypertension. | 2006 | Details |
| A28169 | 16231588 | Eur Rev Med Pharmacol Sci | Hepatic steatosis and vascular disease. | 2006 | Details |
| A28171 | 16231586 | Eur Rev Med Pharmacol Sci | Nonalcoholic fatty liver disease: defining a common problem. | 2006 | Details |
| A28180 | 16225469 | Aliment Pharmacol Ther | Review article: the metabolic syndrome and non-alcoholic fatty liver disease. | 2005 | Details |
| A28191 | 16198623 | Hepatol Res | The role of leptin in progression of non-alcoholic fatty liver disease. | 2005 | Details |
| A28193 | 16198620 | Hepatol Res | Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). | 2005 | Details |
| A28194 | 16197788 | Obes Surg | Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. | 2005 | Details |
| A28220 | 16093589 | Intern Med | Brachial-ankle pulse wave velocity in Japanese university students. | 2005 | Details |
| A28253 | 15946458 | Obes Surg | Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. | 2005 | Details |
| A28266 | 15895401 | Hepatology | Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. | 2005 | Details |
| A28272 | 15859390 | Ann Ital Med Int | [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?]. | 2005 | Details |
| A28279 | 15824194 | Hypertension | Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. | 2005 | Details |
| A28283 | 15811215 | Curr Med Res Opin | A review of the metabolic effects of sibutramine. | 2005 | Details |
| A28298 | 15754745 | Gac Med Mex | [Prevalence of non-alcoholic esteatohepatitis in adults with metabolic syndrome in Oaxaca]. | 2005 | Details |
| A28300 | 15746106 | BMJ | Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. | 2005 | Details |
| A28312 | 15709991 | Aliment Pharmacol Ther | Histological progression of non-alcoholic fatty liver disease in Chinese patients. | 2005 | Details |
| A28321 | 15690483 | Hepatology | Chronological development of elevated aminotransferases in a nonalcoholic population. | 2005 | Details |
| A28325 | 15670668 | Alcohol | Mechanisms of non-alcoholic steatohepatitis. | 2004 | Details |
| A28326 | 15665567 | Korean J Gastroenterol | [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?]. | 2005 | Details |
| A28332 | 15625647 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease: a review of current understanding and future impact. | 2004 | Details |
| A28339 | 15598336 | Pediatr Transplant | Non-alcoholic steatohepatitis in children. | 2004 | Details |
| A28354 | 15513385 | Scand J Gastroenterol | High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. | 2004 | Details |
| A28360 | 15489568 | Eur J Gastroenterol Hepatol | Evaluation and management of non-alcoholic steatohepatitis. | 2004 | Details |
| A28405 | 15194655 | Gut | Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. | 2004 | Details |
| A28409 | 15151626 | J Gastroenterol Hepatol | Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. | 2004 | Details |
| A28415 | 15114294 | Ann Hepatol | Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity. | 2004 | Details |
| A28420 | 15085483 | Semin Liver Dis | Nonalcoholic steatohepatitis. | 2004 | Details |
| A28421 | 15084161 | Am J Transplant | Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. | 2004 | Details |
| A28423 | 15057893 | Hepatology | Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. | 2004 | Details |
| A28450 | 14642613 | J Hepatol | Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. | 2003 | Details |
| A28455 | 14609346 | Drugs | Advances in the understanding and treatment of nonalcoholic fatty liver disease. | 2003 | Details |
| A28469 | 13679007 | Med Hypotheses | Low birth weight: a possible risk factor also for liver diseases in adult life? | 2003 | Details |
| A28475 | 12799409 | JAMA | Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. | 2003 | Details |
| A28486 | 12677985 | Ugeskr Laeger | [Nonalcoholic steatohepatitis--a "new" hepatic disease]. | 2003 | Details |
| A28487 | 12668987 | Hepatology | Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. | 2003 | Details |
| A28526 | 12122357 | Gastroenterol Clin Biol | [Non alcoholic steatohepatitis: a multifactorial, frequent, paucysymptomatic liver disease with a fibrotic outcome]. | 2002 | Details |
| A28552 | 11475019 | Ned Tijdschr Geneeskd | [Abdominal obesity: metabolic complications and consequences for the liver]. | 2001 | Details |
| A28553 | 11473047 | Diabetes | Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. | 2001 | Details |
| A28555 | 11438497 | Gastroenterology | Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. | 2001 | Details |
| A28594 | 1490801 | Int J Clin Pharmacol Ther Toxicol | Pharmacokinetics of trapidil (Rocornal) in patients with chronic liver disease. | 1992 | Details |
| A28678 | 35144487 | Stroke | Number of Affected Relatives, Age, Smoking, and Hypertension Prediction Score for Intracranial Aneurysms in Persons With a Family History for Subarachnoid Hemorrhage. | 2022 | Details |
| A28688 | 35129266 | J Clin Hypertens (Greenwich) | Estimated blood pressure trajectories and hypertension patterns among pregnant women living with HIV, Haiti, 2007-2017. | 2022 | Details |
| A28699 | 35115812 | Int J Gen Med | Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis. | 2022 | Details |
| A28717 | 35101153 | Inflamm Regen | A novel prostaglandin I2 agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice. | 2022 | Details |
| A28740 | 35076966 | Hepatology | Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery. | 2022 | Details |
| A28746 | 35068804 | J Clin Exp Hepatol | Endotipsitis: An Underdiagnosed Complication of Transjugular Intrahepatic Portosystemic Shunts. | 2021 | Details |
| A28806 | 34974327 | Diabetes Metab Syndr | Prevalence of metabolic syndrome in cirrhotics with gastric antral vascular ectasia. | 2021 | Details |
| A28834 | 34923653 | Hepatology | Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. | 2022 | Details |
| A28912 | 34830874 | Cancers (Basel) | The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer. | 2021 | Details |
| A28934 | 34799282 | Dig Liver Dis | The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices. | 2021 | Details |
| A29002 | 34716927 | Hepatology | Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies. | 2021 | Details |
| A29084 | 34604726 | JHEP Rep | Excellent outcomes with liver transplantation in hepatopulmonary syndrome across pre-transplant PaO2 spectrum. | 2021 | Details |
| A29267 | 34332532 | BMC Gastroenterol | Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study. | 2021 | Details |
| A29341 | 34231046 | J Gastroenterol | Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. | 2021 | Details |
| A29342 | 34228859 | Hepatol Res | Evidence-based clinical practice guidelines for liver cirrhosis 2020. | 2021 | Details |
| A29496 | 33982942 | Am J Gastroenterol | Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. | 2021 | Details |
| A29680 | 33690919 | Clin Transplant | Alcohol-related cirrhosis is associated with high coronary artery calcium scores in patients undergoing evaluation for orthotopic liver transplantation. | 2021 | Details |
| A29792 | 33513920 | Biomedicines | Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities. | 2021 | Details |
| A29845 | 33411729 | PLoS One | Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis. | 2021 | Details |
| A30207 | 32808168 | Obes Surg | Bariatric Surgery in Cirrhotic Patients: a Matched Case-Control Study. | 2020 | Details |
| A30327 | 32641471 | Gut | Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. | 2020 | Details |
| A30432 | 32453061 | Am J Gastroenterol | Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg. | 2020 | Details |
| A30521 | 32289534 | Clin Gastroenterol Hepatol | Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease. | 2020 | Details |
| A30564 | 32205234 | Pharmacol Res | Obesity and NRF2-mediated cytoprotection: Where is the missing link? | 2020 | Details |
| A30569 | 32196084 | Mil Med | Health Characteristics of the Madeira Riverine Population. | 2020 | Details |
| A30621 | 32097195 | J Acquir Immune Defic Syndr | Mood Disorders and Increased Risk of Noncommunicable Disease in Adults With HIV. | 2020 | Details |
| A30643 | 32055695 | JGH Open | Explant liver evaluation decodes the mystery of cryptogenic cirrhosis! | 2019 | Details |
| A30652 | 32039404 | JHEP Rep | Beta-blockers in cirrhosis: Evidence-based indications and limitations. | 2019 | Details |
| A30790 | 31777145 | Int J Exp Pathol | The effects of intravitreal H2 S application on apoptosis in the retina and cornea in experimental glaucoma model. | 2019 | Details |
| A31010 | 31399194 | Am J Surg | Roux-en-Y gastric bypass is a safe and effective option that improves major Co-Morbidities associated with obesity in an older, veteran population. | 2019 | Details |
| A31167 | 31113588 | Ann Hepatol | Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center. | 2020 | Details |
| A31229 | 31001415 | F1000Res | Recent advances in managing/understanding the metabolic syndrome. | 2019 | Details |
| A31413 | 30625404 | Clin Gastroenterol Hepatol | Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis. | 2019 | Details |
| A31532 | 30366170 | Int J Surg Case Rep | En bloc liver-kidney transplantation with renal artery variation using donor splenic artery and left gastric artery as inflow to the kidney: Case report. | 2018 | Details |